Literature DB >> 25649108

Commentary on Hey and Kimmelman.

Edward L Korn1, Boris Freidlin2.   

Abstract

Mesh：

Year:  2015        PMID： 25649108     DOI： 10.1177/1740774515569611

Source DB:  PubMed          Journal:  Clin Trials        ISSN： 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  5 in total

1.  Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements.

Authors:  Edward L Korn; Boris Freidlin
Journal:  J Natl Cancer Inst       Date:  2017-06-01       Impact factor: 13.506

2.  A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.

Authors:  Leslie A McClure; Jeff M Szychowski; Oscar Benavente; Robert G Hart; Christopher S Coffey
Journal:  Clin Trials       Date:  2016-04-19       Impact factor: 2.486

3.  Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness Trials.

Authors:  Byron J Gajewski; Jeffrey Statland; Richard Barohn
Journal:  Stat Biopharm Res       Date:  2019-06-26       Impact factor: 1.452

4.  Clinical trialist perspectives on the ethics of adaptive clinical trials: a mixed-methods analysis.

Authors:  Laurie J Legocki; William J Meurer; Shirley Frederiksen; Roger J Lewis; Valerie L Durkalski; Donald A Berry; William G Barsan; Michael D Fetters
Journal:  BMC Med Ethics       Date:  2015-05-03       Impact factor: 2.652

Review 5.  Interim analysis: A rational approach of decision making in clinical trial.

Authors:  Amal Kumar; Bhaswat S Chakraborty
Journal:  J Adv Pharm Technol Res       Date:  2016 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.